Drug Discovery
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
Fibrocell Science Awarded $1.4M FDA Orphan Grant
For the continued clinical development of FCX-007, the Company’s gene therapy candidate for the treatment of RDEB09.25.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
Celltrion, Emory Sign Incubation Agreement
To support the research and development of new drug candidates for atherosclerosis09.24.18
-
Bio News | cGMP Manufacture | Collaborations & Alliances | Drug Development | Drug Discovery | Facilities | Fill/Finish | Industry News
BeiGene Selects GE’s KUBio
For large-scale production of its cancer monoclonal antibodies (mAbs)Videos
-
Bio News | Collaborations & Alliances | Drug Discovery | Industry News | R&D
Propanc, University of Jaén, Spain Enter Collaboration
For the provision of research services and scientific technical advice for the Company's POP1 drug discovery program09.19.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
APEIRON & LDC Enter Partnership
To perform drug discovery activities to optimize and develop novel small molecules addressing immune checkpoints09.19.18
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
Dyadic, Sanofi in Research Collaboration
To explore the potential of its C1 technology to produce multiple types of biologic vaccines and drugs of interest09.18.18
-
Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
AstraZeneca Joins Horizon's Genomics Discovery Initiative
Horizon Discovery's Edit-R crRNA libraries adopted by AstraZeneca as part of its functional genomics discovery platform09.18.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Fate & ONO Enter Development Partnership
For the joint development and commercialization of two off-the-shelf CAR-T cell product candidates09.18.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Evotec, Almirall Sign Research Agreement
To discover and develop first-in-class therapeutics through a novel approach to disrupt cell signalling09.17.18
-
Analytical Services | Bio News | Collaborations & Alliances | Drug Discovery | Industry News | Information Technology | Laboratory Testing | R&D
FloDesign, Cognate Announce Collaboration
To advance the development of life saving therapeutics by improving manufacturing efficiencies using FloDesign's ACP Platform09.12.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D | Trials & Filings
Boehringer Announces Positive Phase III Results
Confirmed that Cyltezo is equivalent to Humira, with no clinically meaningful differences in efficacy or safety09.12.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Athenex & Hanmi Realign Joint Projects
Changes were announced to the Orascovery Program and KX-01 Oral Formulation partnership09.12.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | Trials & Filings
FDA Grants Amgen & AstraZeneca Breakthrough Therapy Designation
For tezepelumab in patients with severe asthma without an eosinophilic phenotype09.07.18
-
Bio News | Breaking News | Drug Development | Drug Discovery | Industry News | Promotions & Moves | R&D
Aileron Therapeutics Names President & CEO
Manuel Aivado, MD, PhD has over 20 years experience, and has served as Aileron’s SVP, CMO, and CSO since 201209.06.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Discovery | Industry News | R&D | Trials & Filings
Gilead, Galapagos Announce Positive Phase 2 Results
In the TORTUGA study of filgotinib, an investigational, selective JAK1 inhibitor for the treatment of ankylosing spondylitis09.06.18
-
Collaborations & Alliances | Drug Discovery
Pfizer, CYTOO in Research and Option Agreement
Aims to develop a target discovery platform for Duchenne Muscular Dystrophy09.06.18
-
Collaborations & Alliances | Drug Development | Drug Discovery
Evotec, Celgene in Third Discovery and Development Pact
Will leverage Evotec's Panomics platform to identify drug targets that are traditionally difficult to track09.06.18
-
Bio News | Collaborations & Alliances | Drug Discovery | Industry News | R&D
IRBM, Merck Enter Discovery Collaboration
To evaluate the potential of peptide-based therapeutic candidates09.05.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | Laboratory Testing | R&D
Key Biologics, BCA Partner for Cell Therapy
Agreement enables deeper support of joint research and product development for cell therapy and regenerative medicine09.05.18
-
Analytical Services | Bio News | Drug Discovery | Industry News | Laboratory Testing
SGS Implements PBMC Analysis
For the collection & use of peripheral blood mononuclear cells (PBMCs) for early phase clinical trials at its CPU in Belgium09.05.18
